Supreme Court rejects challenge to abortion pill mifepristone

By Tashi McQueenAFRO Political Writertmcqueen@afro.comThe U.S. Supreme Court unanimously voted on June 13 to dismiss a challenge to mifepristone, an abortion pill, saying opponents lack standing to contest the Food and Drug Administration’s (FDA) actions concerning the drug.The U.S. Supreme Court kept abortion medication mifepristone on the market in a June 13 unanimous decision. (Photo credit: Unsplash/Christine Sandu)“Today’s decision does not change the fact that the fight for reproductive freedom continues. It does not change the fact that the Supreme Court overturned Roe v. Wade two years ago, and women lost a fundamental freedom,” said President Joe Biden (D) in a statement. “It does mean that mifepristone, or medication abortion, remains available and approved.”The FDA approved mifepristone in September 2000 to be used for terminating a pregnancy up to seven weeks gestation, according to the FDA’s website. In 2016, they approved its use for up to 10 weeks.Democratic nominee for U.S. Senate Angela Alsobrooks (D-Md.), who has been vocal about protecting abortion rights in Congress, commented on the decision.“It was correct that the Supreme Court made the decision to keep this single right intact – women’s access to this particular reproductive medication,” said Alsobrooks in a statement. “But I, like...